HLTH
Closed
Cue Health Inc
0.0045
+0.0045 (0%)
Last Update: 16 Jul 2024 16:30:00
Yesterday: 0.
Day's Range: 0.0042 - 0.006
Send
sign up or login to leave a comment!
When Written:
1.82
Cue Health Inc is a healthcare technology company that develops and manufactures medical diagnostic devices for use in the home and clinical settings. Founded in 2010, the company is headquartered in San Diego, California.
Cue Health's flagship product is the Cue Health Monitoring System, a portable, handheld device that enables users to perform a range of medical tests, including COVID-19 testing, in just minutes. The device uses a disposable cartridge that contains all the necessary reagents and sensors, making it easy to use and highly accurate.
The company has also developed a range of other diagnostic devices, including tests for influenza, strep throat, and fertility. In addition, Cue Health has partnered with several major healthcare organizations, including Johnson & Johnson, to develop and manufacture new medical technologies.
Cue Health has received significant funding from investors, including $100 million in a Series C funding round in 2020. The company has also received emergency use authorization from the US Food and Drug Administration for its COVID-19 testing system, which has been used by several major organizations, including the NFL and the US Department of Defense.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Cue Health's flagship product is the Cue Health Monitoring System, a portable, handheld device that enables users to perform a range of medical tests, including COVID-19 testing, in just minutes. The device uses a disposable cartridge that contains all the necessary reagents and sensors, making it easy to use and highly accurate.
The company has also developed a range of other diagnostic devices, including tests for influenza, strep throat, and fertility. In addition, Cue Health has partnered with several major healthcare organizations, including Johnson & Johnson, to develop and manufacture new medical technologies.
Cue Health has received significant funding from investors, including $100 million in a Series C funding round in 2020. The company has also received emergency use authorization from the US Food and Drug Administration for its COVID-19 testing system, which has been used by several major organizations, including the NFL and the US Department of Defense.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!